Glasgow, United Kingdom

Ross Mclellan

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ross Mclellan: Innovator in Pharmaceutical Chemistry

Introduction

Ross Mclellan is a notable inventor based in Glasgow, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on crystalline forms of aminoguandinium salts. His research has implications for enhancing solubility in medicinal applications.

Latest Patents

Mclellan holds a patent for "Polymorphs of phenyl pyrrole aminoguandium salts." This patent describes crystalline forms of N-{3-[1-(2-nitrophenyl)-1H-pyrrol-2-yl]-allylidene}-aminoguanidinium salts that exhibit high solubility. The disclosure emphasizes the potential use of these crystalline forms in medicine, showcasing Mclellan's commitment to advancing healthcare solutions.

Career Highlights

Ross Mclellan is currently associated with Synact Pharma Aps, where he continues to push the boundaries of pharmaceutical research. His work is characterized by a focus on developing innovative compounds that can lead to improved therapeutic outcomes.

Collaborations

Mclellan collaborates with esteemed colleagues such as Thomas Boesen and Thomas Engelbrecht Nordkild Jonassen. These partnerships enhance the research environment and foster the exchange of ideas, contributing to the advancement of their collective work.

Conclusion

In summary, Ross Mclellan is a distinguished inventor whose work in pharmaceutical chemistry is paving the way for new medicinal applications. His innovative approach and collaborative spirit are vital to the ongoing evolution of the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…